상세 보기
EMPOWER-lung 4: Phase II, randomized, open-label high dose or standard dose cemiplimab alone/plus ipilimumab in the secondline treatment of advanced non-small cell lung cancer (NSCLC)
- Shim, B. Y.;
- Lee, S.;
- de Castro Carpeno, J.;
- Chiu, C-H.;
- Cobo, M.;
- ... Ryu, J. S.;
- 외 7명
Citations
WEB OF SCIENCE
6- 제목
- EMPOWER-lung 4: Phase II, randomized, open-label high dose or standard dose cemiplimab alone/plus ipilimumab in the secondline treatment of advanced non-small cell lung cancer (NSCLC)
- 저자
- Shim, B. Y.; Lee, S.; de Castro Carpeno, J.; Chiu, C-H.; Cobo, M.; Kim, H. R.; Ryu, J. S.; Tarruella, M. M.; Summers, Y.; Thomas, C. A.; Xu, Y.; Lowy, I.; Rietschel, P.
- 발행일
- 2020-09
- 유형
- Meeting Abstract
- 권
- 31
- 페이지
- S820 ~ S820
- 언어
- ENG
- 출판사
- Oxford University Press
- 발행국가
- 영국
- ISSN
- E 1569-8041
P 0923-7534